Does it seem like the number of people you know who have sustained knee injuries has increased recently? That's likely ...
Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback